Healthtech Startups

PreComb is a Swiss biotech company developing its proprietary 3DTwin technology, which combines automated drug testing on patient-derived tumor twins with AI-guided data analysis and response prediction. The technology is designed for use in the clinic to support evidence-based, personalized treatment decisions in oncology.

2 investors

Predicta Med develops a data analytics platform using deep learning to identify at-risk autoimmune disease patients across multiple medical systems, enabling clinicians to intervene earlier and improve diagnostic outcomes.

2 investors

Predictably Human is developing NoMore, an adaptive drug delivery device paired with a personalized digital companion, aimed at patients with mental health conditions, addiction, and other complex disorders. The system is intended to support an ecosystem of digital products and services around treatment.

2 investors

Predictiv Care uses DNA and genomic analysis to identify genetic predispositions so diseases can be predicted and prevented, with a focus on personalized, preventive health. The company aims to make precision and preventive healthcare affordable and understandable for individuals.

2 investors

Preemptive builds a continuous, clinician-guided health monitoring layer positioned beneath primary care, using sensing and AI to detect early physiological changes before symptoms appear. It combines device signals with human interpretation to provide early health signals for individuals within the broader healthcare system.

2 investors

Preferred Homecare provides in-home clinical services and durable medical equipment (DME), including wheelchairs and hospital beds, along with related therapies and products. It serves patients receiving care at home through trained professionals and clinicians.

2 investors

PregnanTech develops a silicone medical device placed around the uterine cervix to help keep the cervix elongated, addressing preterm birth. The device is inserted by a physician as a short outpatient procedure.

2 investors

Prelude Therapeutics is a precision oncology company developing cancer treatments for areas of high unmet need, with a pipeline including selective KAT6A degraders and mutant-selective JAK2V617F JH2 inhibitors. It also applies targeted protein degradation expertise to develop next-generation degrader antibody conjugates (DACs).

2 investors

PreludeDx develops precision diagnostic tests for breast cancer to help physicians make informed treatment decisions and improve patient outcomes. The company serves oncologists, breast surgeons, and pathologists requiring molecular diagnostics for DCIS and other breast cancer subtypes.

2 investors

Premise Health delivers occupational and primary care health services to large employers through on-site clinical delivery and enterprise integration of healthcare operations. The company provides services including primary care, occupational health, pharmacy, and behavioral health programs.

2 investors

Prenosis develops AI-powered precision medicine diagnostics for acute care, built on its Immunix platform and a biobank of clinical data for infection. Its Sepsis ImmunoScore is an FDA-authorized AI diagnostic that integrates biomarkers and clinical data into hospital electronic medical records to diagnose sepsis and predict patient outcomes.

2 investors

Prenostics develops a blood test to detect the earliest stages of cancer (stages 0-2), earlier than current methods, aiming to enable curative treatment. Its initial clinical targets are women at elevated risk of ovarian cancer and people with indeterminate lung nodules.

2 investors

Prescribe FIT offers a remote patient monitoring and virtual lifestyle health coaching platform focused on musculoskeletal (MSK) conditions, helping patients address lifestyle-related root causes to improve surgical and non-surgical outcomes. It serves orthopedic clinics and their patients, providing care coordination, insurance eligibility checks, and at-home coaching.

2 investors

Presence provides remote special education, mental health evaluation, and teletherapy services for PreK–12 schools, connecting students with diverse needs to credentialed practitioners such as speech-language pathologists and school psychologists. The company serves school districts in the United States through a teletherapy technology platform.

2 investors

PreSquared develops predictive analytics software for healthcare, using models trained on hundreds of millions of health records across various systems and provider types. Its algorithms serve providers, care coordinators, payers, and policy makers in production informatics environments.

2 investors

Prevenotics develops AI-based medical diagnostic software focused on gastrointestinal cancer, aimed at improving diagnostic accuracy and identifying pre-cancerous risks to support preventive diagnosis. Its technology targets high-risk groups and seeks to reduce unnecessary biopsies for upper-GI cancer.

2 investors

PREVENT provides health support services targeting high-risk populations with lifestyle-related diseases, with a focus on preventing disease progression and supporting patients' return to daily life. The company expands its expertise across diverse health issues and workplace health management challenges.

2 investors

PreventScripts develops remote patient monitoring solutions that connect primary care providers with patients to improve preventive health outcomes and reduce provider burnout. The platform targets primary care practices and communities facing preventable diseases like metabolic syndrome.

2 investors

Preventive.bio focuses on preventing disease before birth. The page provides no further detail about its products, technology, or customers.

2 investors

Previvor Edge offers a multidisciplinary cancer prevention and early-detection program that combines genetic testing, clinical risk assessment, lifestyle guidance, and screening tools such as multi-cancer tests and full-body MRIs. It serves individuals at elevated cancer risk, including those with a family history, and works with multiple insurance plans as well as self-pay options.

2 investors

Prilenia is a biotechnology company developing treatments for neurodegenerative diseases, including Huntington's disease and amyotrophic lateral sclerosis (ALS). Its research centers on pridopidine, a compound that activates the sigma-1 receptor to restore brain pathways affected by neurodegeneration.

2 investors

PrimaKu operates a healthcare ecosystem in Indonesia connecting parents, pediatricians, and clinics, with apps for child growth monitoring, immunization tracking, and teleconsultations. It also provides an electronic medical record system for clinics and integrates with Satusehat, Indonesia's national medical registry.

2 investors

Primo Capital is an Italian independent alternative investments platform managing funds focused on climate, health, digital, and space technology sectors. It invests in early- and growth-stage startups, with 507M in committed capital across four investment strategies and a portfolio of 66 companies.

2 investors

Princeton Medspa Partners acquires and operates aesthetic and cosmetic medical clinics across the US, including medspas, cosmetic dermatology, plastic surgery, and functional medicine practices. It provides partner clinics with back-office support such as HR, payroll, accounting, marketing, and operations while owners retain focus on patient care.

2 investors